Duke-NUS Medical School, University of Medicine and Pharmacy at Ho Chi Minh city, Agency for Science, Technology and Research (A*STAR) - Genome Institute of Singapore, Hospital of Tropical Diseases - Oxford University Clinical Research Unit, Hospital of Tropical Diseases - Oxford University Clinical Research Unit, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Duke-NUS Medical School, Duke-NUS Graduate Medical School - Programme in Emerging Infectious Diseases, National University of Singapore (NUS) - Saw Swee Hock School of Public Health, Duke-NUS Medical School - Emerging Infectious Diseases Programme and Hospital of Tropical Diseases - Oxford University Clinical Research Unit

Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, Merck & Co., Inc., Merck & Co., Inc., Merck & Co., Inc., Duke-NUS Graduate Medical School Singapore, Duke-NUS Medical School - Emerging Infectious Diseases Programme, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division and Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN)